(Date:11/25/2009)...Newswire-FirstCall/ -- Heska Corporation ( HSKA); ...stic and specialty products to the veterinary indu...stics Corporation for the supply of blood gas prod... market. ,, (Logo: http://www.newscom.com/... Roche share the same passion for innovating in th...
(Date:11/25/2009)...endsResearchGroup,Inc.releasedWave1ofits LaunchTr...esyndicatedmarketresearchprojecttrackingthelauncho...hroughthefirstsixmonthsofavailability.Eachwaveofth...Dermatologistsandqualitativeinformationfromasubset...stouse,typicalpatienttypes,productperceptions,prom...
(Date:11/25/2009)...PRNewswire/ -- Regado Biosciences, a privately hel...c aptamers with active control agents, announced t...resenting at the Piper Jaffray 21st Annual Health ...w York City. Dr. Mazzo,s presentation will be giv... include an overview of the Company,s pipeline wit...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Motorcyclist Lives On Rides On Through Organ Donation 53587 1Motorcyclist Lives On Rides On Through Organ Donation 53587 2Motorcyclist Lives On Rides On Through Organ Donation 53587 3Motorcyclist Lives On Rides On Through Organ Donation 53587 4Motorcyclist Lives On Rides On Through Organ Donation 53587 5AquaHydrate First High Performance Sports Water Targets So Cal Sports Market With Summer Event Support 53585 1AquaHydrate First High Performance Sports Water Targets So Cal Sports Market With Summer Event Support 53585 2AquaHydrate First High Performance Sports Water Targets So Cal Sports Market With Summer Event Support 53585 3Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 1Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 2Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 3Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis 53583 4...ology Annual Congress -, BOSTON, Nov. 12 Bristol...d the results of three post-hoc analyses from two,...batacept) improved daily,activity participation, s...al-role independence and sleep quality in adult rh...nadequate response to one or more,disease-modifyin...
...ed at the,American Academy of Ophthalmology,s 2007... a significant role to play in the diagnosis of ey...nt access to quality care. In the first study, re...d on patients with diabetes being treated in multi... at the number of patients with diabetes over the,...
Other Medicine Technology:Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 2Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 3Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 4Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 5Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 6Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 7Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 8Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 9Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease 2Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease 3(Date:11/27/2009)... 27 The Gymboree Corpora..., CFO/COO, will present at the NASDAQ OMX 23rd Inv...Hotel in London, England, on Wednesday, December 2...ve broadcast of The Gymboree Corporation,s present...oree.com, click on "Our Company" at the bottom of ...
(Date:11/27/2009)...ael, Nov. 27 Shamir Opti... leading provider of innovative products and techn...ay that its board of directors had declared a divi... million (approximately NIS 37.62 million based on...ange), or approximately US$ 0.609 (approximately N...
(Date:11/27/2009)...dented medical, economic burdens, study predicts ,...he number of people with diabetes in the United St... a new study predicts. , That would bring the t... disease, up from 23.7 million today. , , At the...tes will triple, the study also warns, rising from...
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... With cold and flu season upon us, ...ices to control the spread of infections and avoid...to keep ourselves healthy, but to avoid transmitti..., MS, CIC (certified in infection-control), nursin...health at Hospital for Special Surgery (HSS) in Ma...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4...n response to press reports of,parents diluting ba...l expert,and a leading manufacturer of infant form...a responsibly by following the instructions on the...ine, R.D., Ph.D.,director of the first NIH-funded ...
...ept, Inc. ("Biocept"), an emerging,leader in biote...s been,awarded accreditation by the Commission on ...n Pathologists (CAP), based on the results of a re..."excellence,of services being provided." , A...
...inked to better education, mental health 15 years ...) -- Urban kids who took part in a social developm...al health, sexual health, and educational and econ...s faced by many children and families who live in ...
... The four million Americans who,suffer from chron... today with,the announcement of an unprecedented r...e illness and improve diagnosis and treatment of C... As part of this initiative, the CFIDS Associatio...
...tudents pursuing health care careers in New York a...arships from the National Hispanic Health Foundati...essional Student Scholarship Gala at 7 p.m.Decembe...0 awards to the top three students. Other major co...
...ical transcription service provider MedQuist Inc. ...allegations under the False Claims Act that it ove...partment announced today. From 1998 onward, MedQu...f Defense (DOD) and the Public Health Service (PHS...
Other Medicine News:Health News:Cornell Nutritional Expert, Vermont Baby Formula Company Urge Parents Not to Dilute Formula with Extra Water 2Health News:School-Based Program Can Change Kids' Lives 2Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 2Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 3Health News:New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome 4Health News:NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals 2Health News:New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations 2Recipient Needle, 1.0 mm, Spare part for ATA100
Recipient Needle, 0.6 mm, Spare part for ATA100
Recipient Collet, 2.0 mm, Spare part for ATA100
Leveling Pads (Feet, Set of 4), Spare part for ATA100
Medicine Products: